The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback